http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-362972-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-221 |
| filingDate | 1997-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2712fbc3311f345d75951db2e53f13c |
| publicationDate | 1999-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-362972-B |
| titleOfInvention | Use of lower alkanoyl L-carnitines to produce a medicament suitable for the therapeutic treatment of retinopathies |
| abstract | The use of lower alkanoyl L-carnitines (e.g. acetyl L-carnitine) and the pharmacologically acceptable salts thereof to produce a medicament suitable for the therapeutic treatment of retinopathies, e.g. the age-related maculopathy (ARM) and non-age-related maculopathy (nARM), is disclosed. |
| priorityDate | 1996-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406934280 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7045767 |
Total number of triples: 13.